Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
1(25.0%)
Phase 3
1(25.0%)
4Total
N/A(2)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06450704Not ApplicableRecruiting

Cerebral and Anti-inflammatory Response Through Exercise - Mechanisms In Depressive Disorders

Role: collaborator

NCT06963268Phase 3Recruiting

Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)

Role: collaborator

NCT05933876Recruiting

The Impact of Radiotherapy on Oligometastatic Cancer

Role: collaborator

NCT02668978Phase 4Completed

SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial Using HEMOPATCH

Role: lead

NCT03163160Not ApplicableCompleted

Electrolysis Technique vs Manual Therapy in Pelvic Pain

Role: lead

NCT03611504Completed

Hemospray in Gastrointestinal Bleeding: A Real-life Multicenter Cohort

Role: collaborator

NCT01744717Completed

Validation of "Escala de Conductas Indicadoras de Dolor" ESCID Scale for Measuring Pain in Critically Ill Patients

Role: collaborator

All 7 trials loaded